Status:

COMPLETED

A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee

Lead Sponsor:

AbbVie (prior sponsor, Abbott)

Conditions:

Osteoarthritis of the Knee

Eligibility:

All Genders

40-75 years

Phase:

PHASE2

Brief Summary

To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • History of OA of the knee joint and meeting American College of Rheumatology (ACR) Clinical and Radiographic criteria,
  • Pain score as required by the protocol at Screening and Baseline
  • Willing to washout of analgesics and to follow treatment plan, visit schedules and study procedures.
  • Exclusion Criteria
  • History of sensitivity to histamine medications, acetaminophen (paracetamol), or non-steroidal anti-inflammatory drugs (NSAIDs)
  • Active gastrointestinal (GI) disease, GI bleeding or GI ulceration, or history of GI bleeding or GI ulceration in the last 6 months
  • History of major psychiatric disorders
  • Diagnosis of rheumatoid arthritis, autoimmune disorder, arthritis other than osteoarthritis involving the study joint, or other painful syndrome that could interfere with the assessment of pain at the study joint
  • Any cardiac, respiratory, neurological or other medical condition or illness that is not well controlled with treatment

Exclusion

    Key Trial Info

    Start Date :

    September 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2011

    Estimated Enrollment :

    322 Patients enrolled

    Trial Details

    Trial ID

    NCT01207115

    Start Date

    September 1 2010

    End Date

    May 1 2011

    Last Update

    January 7 2013

    Active Locations (38)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 10 (38 locations)

    1

    Site Reference ID/Investigator# 37220

    Chandler, Arizona, United States, 85224

    2

    Site Reference ID/Investigator# 37223

    Tempe, Arizona, United States, 85282

    3

    Site Reference ID/Investigator# 37215

    Tucson, Arizona, United States, 85704

    4

    Site Reference ID/Investigator# 37221

    Anaheim, California, United States, 92801